Similar Items: Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets
- Population genetic structure and cladistic analysis of Trypanosoma brucei isolates
- Measure of molecular diversity within the Trypanosoma brucei subspecies Trypanosoma brucei brucei and Trypanosoma brucei gambiense as revealed by genotypic characterization
- Time-dose-response of Trypanosoma brucei brucei to diminazene aceturate (Berenir) and in vitro simulation of drug-concentration-time profiles in cattle plasma
- An assay for screening drugs against animal-infective blood stream forms of Trypanosoma brucei brucei in vitro
- Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan R) against susceptible drug-resistant Trypanosoma brucei brucei and Trypanosoma brucei evansi
- Molecular variation of Trypanosoma brucei subspecies as revealed by AFLP fingerprinting
Author: Agbo, E.C.
- Population genetic structure and cladistic analysis of Trypanosoma brucei isolates
- Measure of molecular diversity within the Trypanosoma brucei subspecies Trypanosoma brucei brucei and Trypanosoma brucei gambiense as revealed by genotypic characterization
- Genome analysis and DNA marker-based characterisation of pathogenic trypanosomes.
- Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets
Author: Majiwa, Phelix A.O.
- Alterations in gene transcription patterns associated with the Development of isometamidium resistance in Trypanosoma congolense
- Resources available from the African Trypanosome Genome Project
- Variable Surface Glycoprotein RoTat 1.2 PCR as a specific diagnostic tool for the detection of Trypanosoma evansi infections
- Expression of Trypanosoma congolense antigens in spodoptera frugiperdia insect cells
- Identification of a genetic marker for isometamidium chloride resistance in Trypanosoma congolense
- A repetitive deoxyribonucleic acid sequence that distinguishes Trypanosoma simiae from T. congolense